Free Trial

Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Raymond James & Associates

Stericycle logo with Business Services background

Raymond James & Associates decreased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 24.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 579,260 shares of the business services provider's stock after selling 191,775 shares during the period. Raymond James & Associates owned 0.62% of Stericycle worth $33,672,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Capital Research Global Investors raised its holdings in Stericycle by 13.4% during the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider's stock worth $296,762,000 after purchasing an additional 705,586 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in Stericycle by 5.2% in the first quarter. First Eagle Investment Management LLC now owns 242,975 shares of the business services provider's stock valued at $12,817,000 after acquiring an additional 12,000 shares during the last quarter. Robeco Institutional Asset Management B.V. bought a new position in Stericycle in the fourth quarter valued at approximately $156,000. Illinois Municipal Retirement Fund acquired a new stake in Stericycle during the 1st quarter worth $756,000. Finally, Sei Investments Co. raised its position in shares of Stericycle by 5.9% during the 1st quarter. Sei Investments Co. now owns 1,124,481 shares of the business services provider's stock valued at $59,316,000 after acquiring an additional 63,112 shares during the last quarter. Institutional investors own 98.82% of the company's stock.


Wall Street Analysts Forecast Growth

A number of research firms recently commented on SRCL. StockNews.com initiated coverage on Stericycle in a report on Friday. They issued a "hold" rating for the company. Robert W. Baird reduced their price objective on shares of Stericycle from $62.00 to $55.00 and set a "neutral" rating on the stock in a research note on Friday, April 26th. Royal Bank of Canada restated a "sector perform" rating and set a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Truist Financial lifted their price target on shares of Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a research report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Stericycle from $135.00 to $142.00 and gave the company an "outperform" rating in a research report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $74.00.

View Our Latest Research Report on SRCL

Stericycle Stock Down 0.2 %

Shares of NASDAQ:SRCL traded down $0.12 during midday trading on Tuesday, reaching $58.77. 780,645 shares of the company were exchanged, compared to its average volume of 996,200. The firm has a market cap of $5.46 billion, a PE ratio of -267.14, a P/E/G ratio of 3.21 and a beta of 1.11. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $59.45. The stock has a fifty day simple moving average of $58.35 and a two-hundred day simple moving average of $53.27. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

See Also

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Should you invest $1,000 in Stericycle right now?

Before you consider Stericycle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.

While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix is shaking up the streaming world again with its new ad-supported tier, leading to a surge in subscribers and revenue.

Recent Videos

SMCI Stock: Is a Rebound Coming?
FOMC’s Rate Cut Decision Could Drive Market Swings
Rate Cuts May Fuel Continued Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines